Elevance Health
ELV
1,446 hedge funds and large institutions have $96.9B invested in Elevance Health in 2022 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 564 increasing their positions, 500 reducing their positions, and 89 closing their positions.
26% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 89
13% more repeat investments, than reductions
Existing positions increased: 564 | Existing positions reduced: 500
0.52% more ownership
Funds ownership: 88.59% → 89.11% (+0.52%)
0% more funds holding
Funds holding: 1,440 → 1,446 (+6)
5% less call options, than puts
Call options by funds: $614M | Put options by funds: $646M
6% less capital invested
Capital invested by funds: $103B → $96.9B (-$5.89B)
7% less funds holding in top 10
Funds holding in top 10: 68 → 63 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$617M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$417M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$244M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$230M |
| 5 |
Amundi
Paris,
France
|
+$221M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$352M |
| 2 |
BlackRock
New York
|
-$346M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$309M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$231M |
| 5 |
SCM
Steadfast Capital Management
New York
|
-$215M |
ELV Hedge Fund Activity: Q3 2022 in Review
1,446 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2022, worth a combined $96.9B — down 5.7% from $103B a quarter earlier.
Buyers outnumbered sellers: 112 funds opened new ELV positions and 89 closed out — a net gain of 23 holders — while 564 added to existing stakes and 500 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $617M. The largest seller was DZ Bank, cutting an estimated $352M.
- 1,446 institutional investors held Elevance Health (ELV) as of Q3 2022, up from 1,440 in Q2 2022.
- Funds reported $96.9B of Elevance Health stock for Q3 2022, down 5.7% quarter-over-quarter.
- 112 funds opened new Elevance Health positions in Q3 2022 and 89 closed out, a net change of +23 holders.
- The largest Elevance Health buyer in Q3 2022 was T. Rowe Price Associates, an estimated $617M added.
- The largest Elevance Health seller in Q3 2022 was DZ Bank, an estimated $352M sold.
Based on aggregated 13F filings for Q3 2022.